Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;17(1):115-122.
doi: 10.1111/ajco.13425. Epub 2020 Oct 20.

Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018)

Chihyeon Sohng  1 , Hyun Bo Sim  2 , Jun Young Kim  1 , Yangsoo Lim  3 , Man Hoon Han  4 , Hoseok Lee  5 , Byeong-Cheol Ahn  6 , Seung Huh  3 , Seok-Jong Lee  1
Affiliations

Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018)

Chihyeon Sohng et al. Asia Pac J Clin Oncol. 2021 Feb.

Abstract

Background: Sentinel lymph node biopsy (SLNB) of primary cutaneous melanoma as an important staging method has not been popularly undertaken in Korea and only a few studies with small patient numbers have been published.

Aim: We examined the clinical feasibility and overall outcomes of SLNB in acral melanoma (AM) of Korean in Kyungpook National University Hospital (KNUH) over the past 13 years.

Methods: SLNB in AM patients during 2006-2018 were analyzed retrospectively for sentinel lymph node (SLN) harvesting rate, positivity rate, positivity-relevant overall survival (OS) and disease-free survival (DFS), and its side effects.

Results: A total of 109 AM patients who underwent SLNB were enrolled. Harvested nodes were identified from 107 patients and SLN harvesting rate was 98.2%. The mean Breslow thickness (±standard deviation) was 3.38 ± 3.03 mm, and the proportion of ulcerated melanomas was 64%. Twenty-two (20.6%) had a tumor-positive SLN and, among them, 82% (18/22) underwent immediate complete lymph node dissection (CLND). The metastasis-positive nodal basin after CLND was detected in 16.7% of cases (3/18). Tumor-negative SLN cohorts showed significantly better OS and DFS than tumor-positive ones (P = 0.006 and P < 0.001 for each). Two side effects, one seroma and one lymphocele, were observed without major sequelae.

Conclusion: SLNB, crucial management of melanoma, proved its efficacy to predict patients' prognosis and could be performed successfully and safely in Korean AM patients by interdisciplinary cooperation between dermatology and other surgical departments. SLN(-) showed significantly better OS and DFS than SLN(+). Significant risk factors for DFS were Breslow thickness, the presence of ulceration and the presence of SLN metastasis. SLNB should be encouraged in order to stage melanoma accurately and direct the proper management in Korean AM.

Keywords: Korean; acral melanoma; malignant melanoma; prognosis; sentinel lymph node biopsy; survival.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

REFERENCES

    1. Wisco OJ, Sober AJ. Prognostic factors for melanoma. Dermatol Clin. 2012;30:469-485.
    1. Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370:599-609.
    1. Roh MR, Kim J, Chung KY. Treatment and outcomes of melanoma in acral location in Korean patients. Yonsei Med J. 2010;51:562-568.
    1. Otsuka M, Yamasaki O, Kaji T, et al. Sentinel lymph node biopsy for 102 patients with primary cutaneous melanoma at a single Japanese institute. J Dermatol. 2015;42:954-961.
    1. Uhara H, Takata M, Saida T. Sentinel lymph node biopsy in Japan. Int J Clin Oncol. 2009;14:490-496.

LinkOut - more resources